Pharmacological Actions Of Dashamoola In The Management Of Udavartini Yonivyapad: An Integrative Review Of Anti-Inflammatory, Analgesic, And Spasmolytic Pathways

Abstract

Primary Dysmenorrhea (PD), correlated classically with Udavartini Yonivyapad, is a highly prevalent gynecological disorder characterized by painful menstruation (Kashtartava) affecting up to 50% of adult women globally. The pathophysiology involves the hyperactivity of uterine musculature driven primarily by the excessive synthesis of prostaglandins (PGF$_{2\alpha}$). In Ayurveda, Udavartini is recognized as a Vata-dominant pathology involving the upward and obstructed movement (Udavarta) of Apana Vayu, leading to spasmodic pain that is immediately relieved upon menstrual discharge (Artava). Conventional pharmacological interventions, mainly Non-Steroidal Anti-inflammatory Drugs (NSAIDs), provide symptomatic relief but are associated with recurring symptoms and significant long-term adverse effects. 

Objectives: This review aims to systematically synthesize the classical Ayurvedic understanding of Udavartini Yonivyapad with modern pharmacological evidence, establishing the mechanistic basis for the anti-inflammatory, analgesic, and spasmolytic actions of Dashamoola (The Ten Roots) in managing this disorder.

Methodology: A critical integrative literature review was conducted utilizing classical Ayurvedic texts (Charaka Samhita, Sushruta Samhita, Ashtanga Hridaya) to delineate the Nidana and Samprapti of Udavartini, alongside comprehensive searches of contemporary, indexed scientific databases (PubMed, Scopus) focusing on Dashamoola extracts, their constituents, and molecular targets implicated in pain and spasm (e.g., Cyclooxygenase inhibition, Calcium Channel Blockade, TNF-α modulation).

Results/Discussion: Dashamoola, characterized by Ushna Virya (hot potency) and Vata-Shamaka properties, has demonstrated significant efficacy in experimental models, exhibiting anti-inflammatory and analgesic effects comparable to standard NSAIDs like Aspirin and Diclofenac. This action is attributed to the inhibition of prostaglandin synthesis. Crucially, specific phytochemicals derived from Dashamoola components, such as coumarins (from Aegle marmelos) and steroidal saponins (from Tribulus terrestris), are implicated in uterine smooth muscle relaxation .Conclusion: Dashamoola acts as a potent, multi-target therapeutic agent that achieves Samprapti Vighatana (breaking the pathogenesis) by facilitating Apana Vayu Anulomana and simultaneously modulating key inflammatory and spasmodic pathways. Its validated pharmacological properties establish it as a safe and highly efficacious alternative for the comprehensive management of spasmodic dysmenorrhea.